Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia

Shock

Volumn 28, Issue 5, 2007, Pages 582-588

  Kadl, Alexandra ^a   Pontiller, Jens ^b   Exner, Markus ^b   Leitinger, Norbert ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial leukocyte interaction; Inflammation; LPS

Indexed keywords

BILIRUBIN; CELL ADHESION MOLECULE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ANTIOXIDANT ACTIVITY; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL INTERACTION; CELL ISOLATION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; ENDOTOXEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; SEPTIC SHOCK; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BILIRUBIN; BILIVERDINE; CELL ADHESION MOLECULES; CELL COMMUNICATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTOXEMIA; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LEUKOCYTES; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; RATS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37349108810     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31804d41dd     Document Type: Article

References (37)

1. Dennery PA, Weng YH, Stevenson DK, Yang G: The biology of bilirubin production. J Perinatol 21(suppl 1):17-20, 2001.
2. Dennery PA, Seidman DS, Stevenson DK: Neonatal hyperbilirubinemia. N Engl J Med 344:581-590, 2001.
3. Yeung CY, Ngai KC: Cytokine- and endotoxin-enhanced bilirubin cytotoxicity. J Perinatol 21(suppl 1):56-58, 2001.
4. Wiedemann M, Kontush A, Finckh B, Hellwege HH, Kohlschutter A: Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res 53:843-849, 2003.
5. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235:1043-1046, 1987.
6. Morimatsu H, Takahashi T, Maeshima K, Inoue K, Kawakami T, Shimizu H, Takeuchi M, Yokoyama M, Katayama H, Morita K: Increased heme catabolism in critically ill patients: correlation among exhaled carbon monoxide, arterial carboxyhemoglobin, and serum bilirubin IXalpha concentrations. Am J Physiol Lung Cell Mol Physiol 290:L114-L119, 2006.
7. Najib-Farah : Defensive role of bilirubinaemia in pneumococcal infection. Lancet 1:505-506, 1937.
8. Sedlak TW, Snyder SH: Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113:1776-1782, 2004.
9. Novotny L, Vitek L: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 228:568-571, 2003.
10. Vitek L, Novotny L, Sperl M, Holaj R, Spacil J: The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis 21:408-414, 2006.
11. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, Kotal P: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160:449-456, 2002.
12. Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F: Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 114:1476-1481, 2006.
13. Sarady-Andrews JK, Liu F, Gallo D, Nakao A, Overhaus M, Ollinger R, Choi AM, Otterbein LE: Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289:L1131-L1137, 2005.
14. Wang WW, Smith DL, Zucker SD: Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40:424-433, 2004.
15. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, et al.: Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 19:1890-1892, 2005.
16. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, Suematsu M: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85:663-671, 1999.
17. Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD: Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 174:3709-3718, 2005.
18. Wang H, Lee SS, Dell'Agnello C, Tchipashvili V, D'Avilla J, Czismadia E, Chin BY, Bach FH: Bilirubin can induce tolerance to islet allografts. Endocrinology 147:762-768, 2006.
19. Yamashita K, Ollinger R, McDaid J, Sakahama H, Wang H, Tyagi S, Csizmadia E, Smith NR, Soares MP, Bach FH: Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 20:776-778, 2006.
20. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Otterbein LE, et al.: Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5:282-291, 2005.
21. Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, Bauer AJ: Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 290:G695-G703, 2006.
22. Nieuwenhuijzen GA, Meyer MP, Hendriks T, Goris RJ: Deficiency of complement factor C5 reduces early mortality but does not prevent organ damage in an animal model of multiple organ dysfunction syndrome. Crit Care Med 23:1686-1693, 1995.
23. Isakson BE, Duling BR: Heterocellular contact at the myoendothelial junction influences gap junction organization. Circ Res 97:44-51, 2005.
24. Wellmann S, Taube T, Paal K, Graf VE, Geilen W, Seifert G, Eckert C, Henze G, Seeger K: Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by Light-Cycler technology. Clin Chem 47(4):654-660.
25. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:E45, 2001.
26. Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982.
27. Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD: Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 100:4156-4161, 2003.
28. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH: Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172:3553-3563, 2004.
29. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y: Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25:155-160, 2005.
30. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, Vercellotti GM: Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116:808-816, 2006.
31. Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM: Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 27:739-745, 2002.
32. Kaur H, Hughes MN, Green CJ, Naughton P, Foresti R, Motterlini R: Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett 543:113-119, 2003.
33. Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH: Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40:1333-1341, 2004.
34. Stocker R, Glazer AN, Ames BN: Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 84:5918-5922, 1987.
35. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, et al.: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4:1073-1077, 1998.
36. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graca-Souza AV, Liloia A, Soares MP, et al.: Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112:1030-1039, 2005.
37. Baranano DE, Rao M, Ferris CD, Snyder SH: Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 99:16093-16098, 2002.